• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织金属蛋白酶抑制因子-3是聚集蛋白聚糖酶1(含血小板反应蛋白基序的解聚素样金属蛋白酶-4)和聚集蛋白聚糖酶2(含血小板反应蛋白基序的解聚素样金属蛋白酶-5)的强效抑制剂。

TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5).

作者信息

Kashiwagi M, Tortorella M, Nagase H, Brew K

机构信息

Department of Biochemistry and Molecular Biology, University of Miami School of Medicine, Miami, Florida 33101, USA.

出版信息

J Biol Chem. 2001 Apr 20;276(16):12501-4. doi: 10.1074/jbc.C000848200. Epub 2001 Jan 23.

DOI:10.1074/jbc.C000848200
PMID:11278243
Abstract

The proteoglycan aggrecan is an important major component of cartilage matrix that gives articular cartilage the ability to withstand compression. Increased breakdown of aggrecan is associated with the development of arthritis and is considered to be catalyzed by aggrecanases, members of the ADAM-TS family of metalloproteinases. Four endogenous tissue inhibitors of metalloproteinases (TIMPs) regulate the activities of functional matrix metalloproteinases (MMPs), enzymes that degrade most components of connective tissue, but no endogenous factors responsible for the regulation of aggrecanases have been found. We show here that the N-terminal inhibitory domain of TIMP-3, a member of the TIMP family that has functional properties distinct from other TIMPs, is a strong inhibitor of human aggrecanases 1 and 2, with K(i) values in the subnanomolar range. This truncated inhibitor, which lacks the C-terminal domain that is responsible for interactions with molecules other than active metalloproteinases, is produced at high yield by bacterial expression and folding from inclusion bodies. This provides a starting point for developing a biologically available aggrecanase inhibitor suitable for the treatment of arthritis.

摘要

蛋白聚糖聚集蛋白聚糖是软骨基质的一种重要主要成分,它赋予关节软骨承受压力的能力。聚集蛋白聚糖分解增加与关节炎的发展相关,并且被认为是由聚集蛋白聚糖酶催化的,聚集蛋白聚糖酶是金属蛋白酶ADAM-TS家族的成员。四种内源性金属蛋白酶组织抑制剂(TIMPs)调节功能性基质金属蛋白酶(MMPs)的活性,MMPs是降解结缔组织大多数成分的酶,但尚未发现负责调节聚集蛋白聚糖酶的内源性因子。我们在此表明,TIMP-3的N端抑制结构域是TIMP家族的成员,其功能特性与其他TIMPs不同,是人类聚集蛋白聚糖酶1和2的强效抑制剂,其抑制常数(K(i))值在亚纳摩尔范围内。这种截短的抑制剂缺乏负责与活性金属蛋白酶以外的分子相互作用的C端结构域,通过细菌表达和从包涵体折叠可高产获得。这为开发适用于治疗关节炎的具有生物活性的聚集蛋白聚糖酶抑制剂提供了一个起点。

相似文献

1
TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5).组织金属蛋白酶抑制因子-3是聚集蛋白聚糖酶1(含血小板反应蛋白基序的解聚素样金属蛋白酶-4)和聚集蛋白聚糖酶2(含血小板反应蛋白基序的解聚素样金属蛋白酶-5)的强效抑制剂。
J Biol Chem. 2001 Apr 20;276(16):12501-4. doi: 10.1074/jbc.C000848200. Epub 2001 Jan 23.
2
The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation.ADAM-TS4(聚糖酶-1)和ADAM-TS5(聚糖酶-2)在软骨降解模型中的作用。
Osteoarthritis Cartilage. 2001 Aug;9(6):539-52. doi: 10.1053/joca.2001.0427.
3
Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4).金属蛋白酶组织抑制剂(TIMP - 1、2、3和4)对ADAMTS4(软骨聚集蛋白聚糖酶 - 1)的抑制作用
FEBS Lett. 2001 Apr 13;494(3):192-5. doi: 10.1016/s0014-5793(01)02323-7.
4
Characterization of human aggrecanase 2 (ADAM-TS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4).人聚集蛋白聚糖酶2(ADAM-TS5)的特性:底物特异性研究及与聚集蛋白聚糖酶1(ADAM-TS4)的比较
Matrix Biol. 2002 Oct;21(6):499-511. doi: 10.1016/s0945-053x(02)00069-0.
5
Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage.抑制ADAM-TS4和ADAM-TS5可防止骨关节炎软骨中聚集蛋白聚糖的降解。
J Biol Chem. 2002 Jun 21;277(25):22201-8. doi: 10.1074/jbc.M200431200. Epub 2002 Apr 15.
6
Thyroid hormone enhances aggrecanase-2/ADAM-TS5 expression and proteoglycan degradation in growth plate cartilage.甲状腺激素可增强生长板软骨中聚集蛋白聚糖酶-2/ADAM-TS5的表达及蛋白聚糖的降解。
Endocrinology. 2003 Jun;144(6):2480-8. doi: 10.1210/en.2002-220746.
7
Fibroblast growth factor 2 inhibits induction of aggrecanase activity in human articular cartilage.成纤维细胞生长因子2抑制人关节软骨中聚集蛋白聚糖酶活性的诱导。
Arthritis Rheum. 2008 Nov;58(11):3498-509. doi: 10.1002/art.24025.
8
Aggrecanases and cartilage matrix degradation.聚集蛋白聚糖酶与软骨基质降解
Arthritis Res Ther. 2003;5(2):94-103. doi: 10.1186/ar630. Epub 2003 Feb 14.
9
Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro.体内和体外人关节软骨细胞中胶原酶和聚集蛋白聚糖酶的相对信使核糖核酸表达谱分析
Arthritis Rheum. 2002 Oct;46(10):2648-57. doi: 10.1002/art.10531.
10
Aggrecanase and aggrecan degradation in osteoarthritis: a review.骨关节炎中的聚集蛋白聚糖酶与聚集蛋白聚糖降解:综述
J Int Med Res. 2008 Nov-Dec;36(6):1149-60. doi: 10.1177/147323000803600601.

引用本文的文献

1
Parallel Networks to Predict TIMP and Protease Cell Activity of Nucleus Pulposus Cells Exposed and Not Exposed to Pro-Inflammatory Cytokines.用于预测暴露和未暴露于促炎细胞因子的髓核细胞中组织金属蛋白酶抑制剂(TIMP)和蛋白酶细胞活性的并行网络
JOR Spine. 2025 Feb 20;8(1):e70051. doi: 10.1002/jsp2.70051. eCollection 2025 Mar.
2
Nucleus pulposus cell network modelling in the intervertebral disc.椎间盘髓核细胞网络建模
NPJ Syst Biol Appl. 2025 Jan 31;11(1):13. doi: 10.1038/s41540-024-00479-6.
3
Unveiling TIMPs: A Systematic Review of Their Role as Biomarkers in Atherosclerosis and Coronary Artery Disease.
揭示金属蛋白酶组织抑制因子:对其作为动脉粥样硬化和冠状动脉疾病生物标志物作用的系统评价。
Diseases. 2024 Aug 2;12(8):177. doi: 10.3390/diseases12080177.
4
The role of inflammatory mediators and matrix metalloproteinases (MMPs) in the progression of osteoarthritis.炎症介质和基质金属蛋白酶(MMPs)在骨关节炎进展中的作用。
Biomater Biosyst. 2024 Feb 21;13:100090. doi: 10.1016/j.bbiosy.2024.100090. eCollection 2024 Mar.
5
New insights about endometriosis-associated ovarian cancer: pathogenesis, risk factors, prediction and diagnosis and treatment.子宫内膜异位症相关卵巢癌的新见解:发病机制、危险因素、预测、诊断与治疗
Front Oncol. 2024 Feb 7;14:1329133. doi: 10.3389/fonc.2024.1329133. eCollection 2024.
6
The TIMP protein family: diverse roles in pathophysiology.TIMP 蛋白家族:在病理生理学中的多种作用。
Am J Physiol Cell Physiol. 2024 Mar 1;326(3):C917-C934. doi: 10.1152/ajpcell.00699.2023. Epub 2024 Jan 29.
7
Synergetic enrichment of aggrecan in nucleus pulposus cells by scAAV6-shRNA-mediated knockdown of aggrecanase-1 and aggrecanase-2.通过 scAAV6-shRNA 介导的 aggrecanase-1 和 aggrecanase-2 敲低,协同增强椎间盘细胞核心蛋白聚糖。
Exp Biol Med (Maywood). 2023 Jul;248(13):1134-1144. doi: 10.1177/15353702231171905. Epub 2023 Jun 24.
8
Bifidobacterium longum BORI inhibits pain behavior and chondrocyte death, and attenuates osteoarthritis progression.长双歧杆菌 BORI 抑制疼痛行为和软骨细胞死亡,并减轻骨关节炎的进展。
PLoS One. 2023 Jun 23;18(6):e0286456. doi: 10.1371/journal.pone.0286456. eCollection 2023.
9
Targeting Some Key Metalloproteinases by Nano-Naringenin and as a Novel Strategy for Treatment of Osteoarthritis in Rats.纳米柚皮素靶向某些关键金属蛋白酶作为治疗大鼠骨关节炎的新策略
Pharmaceuticals (Basel). 2023 Feb 8;16(2):260. doi: 10.3390/ph16020260.
10
Exosomal transfer of osteoclast-derived miRNAs to chondrocytes contributes to osteoarthritis progression.破骨细胞衍生的 miRNA 通过外泌体转移到软骨细胞促进骨关节炎进展。
Nat Aging. 2021 Apr;1(4):368-384. doi: 10.1038/s43587-021-00050-6. Epub 2021 Apr 15.